Fabi A, Carbognin L, Botticelli A, Paris I, et al. Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer. NPJ Breast Cancer 2024;10:13.
PMID: 38316819